A test that sounds almost too simple to work may soon become a standard part of NHS care. The “sponge on a string” test could change how doctors investigate heartburn and look for early signs of oesophageal cancer.
What has been announced?
The National Institute for Health and Care Excellence (NICE) published draft guidance on 16 November 2026 proposing Cytosponge and EndoSign for selected people with persistent reflux (GORD) or Barrett’s oesophagus. The draft is not final. The consultation closes on 7 December 2026, a committee meets on 16 December, and final guidance is expected in February 2027.
How does the test work?
The test is called a capsule sponge test. The kit contains a small capsule holding a compressed sponge attached to a surgical thread, and a nurse usually carries out the test. The patient swallows the capsule while holding the string. After about five minutes the capsule dissolves and the sponge expands. The sponge collects cells from the lining of the food pipe as it is pulled back up. Those cells are then sent to a lab to be checked for markers of Barrett’s oesophagus or oesophageal cancer.
Barrett’s oesophagus is a condition in which cells in the food pipe change, often after long-term acid reflux. In some people, these cells grow abnormally and can develop into oesophageal cancer.
Why does it matter?
It could shorten waits. Endoscopy is the main way oesophageal cancer is diagnosed, and waiting lists are long. An NHS England evaluation found that 78% of the patients assessed did not have Barrett’s oesophagus and could be managed without an endoscopy. Reducing pressure on endoscopy services is one of the main reasons NICE is considering the technology.
It is gentler for patients. The test is less invasive and quicker than a gastroscopy. The most common side effect is a sore throat. In an NHS trial survey, 94% of patients reported only mild pain or none at all.
It may save money. Trial results suggest that replacing an endoscopy with the sponge test saves around £400 per procedure.
Early detection matters. Cancer Research UK says fewer than 20% of oesophageal cancer patients survive five or more years after diagnosis. Finding the condition earlier gives people a better chance.
What are the limitations?
The sponge test is not a replacement for every endoscopy. People with abnormal results may still need an endoscopy so doctors can examine the oesophagus and take tissue samples. The draft guidance also applies only to selected groups. It covers people with persistent acid reflux and multiple risk factors who do not need an urgent suspected-cancer referral.
There are some practical points too:
- NICE estimates that around 95 in 100 people can swallow the capsule successfully after one or more attempts.
- In very rare cases (fewer than 1 in 5,000), the sponge detaches from the string and stays in the stomach, and an endoscopy is needed to remove it.
What’s next?
The test is already in use in parts of the UK. NHS England has announced a two-year pilot, due to start in early 2026, in which dozens of Boots pharmacies in London and the East Midlands will offer the test to around 1,500 people who frequently buy over-the-counter heartburn remedies and have not yet seen a GP. Larger research is also under way. The BEST4 trial will recruit 120,000 people to see whether the test can reduce deaths from oesophageal cancer.
Should you do anything now?
You can’t ask for the test yet. If you get heartburn or reflux often, or it keeps coming back despite treatment, see your GP rather than relying on over-the-counter remedies. Also seek medical advice promptly if you have trouble swallowing, unexplained weight loss, or persistent vomiting. Those symptoms need proper assessment.
The bottom line
The “sponge on a string” is a small device that could make a big difference. It could mean quicker checks for many patients and shorter endoscopy queues for those who need them most. The decision is still in draft, and the final NICE guidance is expected in early 2027.
This post is for general information only and is not medical advice. If you are worried about your symptoms, speak to your GP.